Cargando…
Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care
RATIONALE: Autism spectrum disorders (ASDs) affect 1 % of children, having significant impact on health and social outcomes. Psychotropic medication use by individuals with ASD in the USA increased over time, and polypharmacy occurred in >50 % of those prescribed. In the UK, no psychotropic drugs...
Autores principales: | Murray, Macey L., Hsia, Yingfen, Glaser, Karen, Simonoff, Emily, Murphy, Declan G. M., Asherson, Philip J., Eklund, Hanna, Wong, Ian C. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932167/ https://www.ncbi.nlm.nih.gov/pubmed/23681164 http://dx.doi.org/10.1007/s00213-013-3140-7 |
Ejemplares similares
-
Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK
por: Alfageh, Basmah H., et al.
Publicado: (2019) -
The autism spectrum disorders (ASD)
por: Gambino, G
Publicado: (2014) -
Predicting the diagnosis of autism in adults using the Autism-Spectrum
Quotient (AQ) questionnaire
por: Ashwood, K. L., et al.
Publicado: (2016) -
Screening for co‐occurring conditions in adults with autism spectrum disorder using the strengths and difficulties questionnaire: A pilot study
por: Findon, James, et al.
Publicado: (2016) -
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis
por: Siafis, Spyridon, et al.
Publicado: (2020)